Patents by Inventor Bruce R. Gordon

Bruce R. Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds
    Patent number: 9023833
    Abstract: The invention relates to a method for treating sepsis in subjects who exhibit serum albumin levels, and one of total cholesterol or HDL levels, above minimum threshold values. The method involves intravenous administration of an emulsion, which contains a phospholipid, a neutral lipid, and a cholate salt.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: May 5, 2015
    Assignee: Sepsicure, LLC
    Inventors: Daniel M. Levine, Thomas S. Parker, Bruce R. Gordon, Stuart D. Saal
  • METHOD FOR TREATING SEPSIS IN PATIENTS WITH ALBUMIN, CHOLESTEROL AND HDL LEVELS ABOVE MINIMUM THRESHOLDS
    Publication number: 20140171391
    Abstract: The invention relates to a method for treating sepsis in subjects who exhibit serum albumin levels, and one of total cholesterol or HDL levels, above minimum threshold values. The method involves intravenous administration of an emulsion, which contains a phospholipid, a neutral lipid, and a cholate salt.
    Type: Application
    Filed: December 18, 2012
    Publication date: June 19, 2014
    Applicant: THE ROGOSIN INSTITUTE
    Inventors: Daniel M. LEVINE, Thomas S. Parker, Bruce R. Gordon, Stuart D. Saal
  • Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
    Patent number: 5674855
    Abstract: Treatment and prophylaxis of endotoxin caused toxicity is disclosed. This is accomplished by administering phospholipid containing compositions to the subject. The compositions are protein and peptide free, and may contain triglycerides, or other polar or neutral lipids.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 7, 1997
    Assignee: The Rogosin Institute
    Inventors: Daniel M. Levine, Thomas S. Parker, Albert L. Rubin, Bruce R. Gordon, Stuart D. Saal
  • Protein and peptide free, neutral lipid and phospholipid containing compositions useful in treating endotoxemia
    Patent number: 5614507
    Abstract: Protein and peptide free compositions are described, which are useful in treating endotoxemia. The compositions contain a phospholipid and a neutral lipid, preferably phosphatidylcholine and triglyceride.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: March 25, 1997
    Assignee: The Rogosin Institute
    Inventors: Thomas S. Parker, Daniel M. Levine, Albert L. Rubin, Bruce R. Gordon, Stuart D. Saal
  • Compositions useful in prophylaxis and therapy of endotoxin related conditions
    Patent number: 5587366
    Abstract: Treatment and prophylaxis of endotoxin caused toxicity is disclosed. This is accomplished by administering phospholipid containing compositions to the subject. The compositions are protein and peptide free, and may contain triglycerides, or other polar or neutral lipids.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 24, 1996
    Assignee: The Rogosin Institute
    Inventors: Thomas S. Parker, Daniel M. Levine, Albert L. Rubin, Bruce R. Gordon, Stuart D. Saal
  • Methods useful in endotoxin based therapy
    Patent number: 5506218
    Abstract: Treatment and prophylaxis of endotoxin caused toxicity is disclosed. This is accomplished by administering phospholipid containing compositions to the subject. The compositions are protein and peptide free, and may contain triglycerides, or other polar or neutral lipids.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: April 9, 1996
    Assignee: The Rogosin Institute
    Inventors: Thomas S. Parker, Daniel M. Levine, Albert L. Rubin, Bruce R. Gordon, Stuart D. Saal
  • Reconstituted HDL particles and uses thereof
    Patent number: 5128318
    Abstract: A reconstituted high density lipoprotein containing particle is disclosed. The particle is useful in removing excess lipid soluble material from a subject to which it is administered, as well as in delivery of lipid soluble pharmaceuticals to subjects or patients.
    Type: Grant
    Filed: October 27, 1988
    Date of Patent: July 7, 1992
    Assignee: The Rogosin Institute
    Inventors: Daniel M. Levine, Sanford R. Simon, Bruce R. Gordon, Thomas S. Parker, Stuart D. Saal, Albert L. Rubin